Publications found:
194
Sort by:
Pyelonephritis Treatment Market - 2026-2033
US$ 3,400.00
Pyelonephritis Treatment Market reached US$ 1,073.23 million in 2025 and is expected to reach US$ 1,682.83 billion by 2033, growing with a CAGR of 5.80% during the forecast period 2026-2033. The Pyelo...
May 2026
50 pages
Chagas Disease Market - 2026-2033
US$ 3,400.00
Chagas Disease Market reached US$ 308 million in 2025 and is expected to reach US$ 536 million by 2033, growing with a CAGR of 7.20% during the forecast period 2026-2033. The Chagas Disease Market eme...
May 2026
40 pages
Smallpox Treatment Market - 2026-2033
US$ 3,400.00
The Smallpox Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpar...
May 2026
44 pages
Ebola Virus Infection Market - 2026-2033
US$ 3,400.00
Ebola Virus Infection Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Ebola Virus Infection Market emerges as a key focus in DataM Intelligence latest in-depth analy...
May 2026
47 pages
Tuberculosis Drug Market - 2026-2033
US$ 3,400.00
Tuberculosis Drug Market reached US$ 2.57 billion in 2025 and is expected to reach US$ 3.78 billion by 2033, growing with a CAGR of 4.90% during the forecast period 2026-2033. The Tuberculosis Drug Ma...
May 2026
43 pages
Tularemia Treatment Market - 2026-2033
US$ 3,400.00
Tularemia Treatment Market reached USD 326.46 million in 2025 and is expected to reach USD 456.23million by 2033, growing with a CAGR of 6.80% during the forecast period 2026-2033. The Tularemia Treat...
May 2026
45 pages
Viral Gastroenteritis Market Forecasts to 2034 – Global Analysis By Type (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus and Other Types), Diagnosis (Physical Examination and Rapid Stool Test), Treatment (Intravenous Fluids, Antimotility Agents, Electrolytes, Antiemetic Drugs, Antidiarrheal Drugs and Other Treatments), Drug (Antibiotics, Antacids, Laxatives, Antimotility Agents, Antiemetics, Chemotherapy Drugs and Other Drugs), Dosage, Indication, Route of Administration, Distribution Channel, End User and by Geography
US$ 4,150.00
According to Stratistics MRC, the Global Viral Gastroenteritis Market is accounted for $57.0 billion in 2026 and is expected to reach $95.1 billion by 2034 growing at a CAGR of 6.6% during the forecas...
April 2026
200 pages
Cutaneous And Systemic Leishmaniasis Market - 2026-2033
US$ 3,400.00
Cutaneous And Systemic Leishmaniasis Market reached US$372.4 million in 2025 and is expected to reach US$470.5 million by 2033, growing with a CAGR of 3.00% during the forecast period 2026-2033. The C...
April 2026
62 pages
Epidural Abscess Treatment Market - 2026-2033
US$ 3,400.00
Epidural Abscess Treatment Market reached USD 52.65 billion in 2025 and is expected to reach USD 105.12 billion by 2033, growing with a CAGR of 9.00% during the forecast period 2026-2033. The Epidural...
April 2026
52 pages
Hospital Acquired Infections Market - 2026-2033
US$ 3,400.00
Hospital Acquired Infections Market reached USD 16.10 billion in 2025 and is expected to reach USD 21.80 billion by 2033, growing with a CAGR of 3.80% during the forecast period 2026-2033. The Hospita...
April 2026
54 pages
Global Clostridium Difficile Market Growth 2026-2032
US$ 3,660.00
The global Clostridium Difficile market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Clostridium Difficile is a ba...
February 2026
82 pages
Hepatitis B & C Therapeutics Market - 2025-2033
US$ 3,400.00
Hepatitis B & C Therapeutics Market reached US$ 17.02 billion in 2024 and is expected to reach US$ 20.83 billion by 2033, growing with a CAGR of 3.40% during the forecast period 2026-2033. The Hepatit...
February 2026
54 pages
Sepsis Treatment Market - 2024-2031
US$ 3,400.00
Sepsis Treatment Marketis is growing with a CAGR of 9.50% during the forecast period 2026-2035. The Sepsis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
February 2026
42 pages
Typhoid Fever Market - 2025-2033
US$ 3,400.00
Typhoid Fever Market reached US$373.72Million in 2024 and is expected to reach US$ 858.77Million by 2033, growing with a CAGR of 9.70% during the forecast period 2026-2033. The Typhoid Fever Market em...
January 2026
39 pages
Global Lamivudine Drugs Market Growth 2026-2032
US$ 3,660.00
The global Lamivudine Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Lamivudine is an oral antiviral me...
January 2026
132 pages
Global Oral Adefovir Drugs Market Growth 2026-2032
US$ 3,660.00
The global Oral Adefovir Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Oral adefovir drugs are an anti...
January 2026
113 pages
Herpes Labialis Drugs Market - 2024-2031
US$ 3,400.00
Herpes Labialis Drugs Market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031, growing with a CAGR of 4.80% during the forecast period 2026-2031. The Herpes Labialis D...
January 2026
47 pages
Invasive Fungal Infection Treatment Market - 2024-2031
US$ 3,400.00
Invasive Fungal Infection Treatment Market reached US$ 10.6 billion in 2023 and is expected to reach US$ 14.6 billion by 2031, growing with a CAGR of 4.10% during the forecast period 2026-2031. The In...
January 2026
61 pages
Chlamydia Infection Treatment Market - 2024-2031
US$ 3,400.00
Chlamydia Infection Treatment Market reached US$ 1.71 billion in 2023 and is expected to reach US$ 2.46 billion by 2031, growing with a CAGR of 4.70% during the forecast period 2026-2031. The Chlamydi...
January 2026
55 pages
Global Acinetobacter Infections Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Acinetobacter Infections Treatment, with price, sales, revenue and global market share of Acinetobacter Infections Treatment in 2017 and 2018. Chapter 3, the Acinetobacter Infections Treatment competitive situation, sales, revenue and global market share ...
January 2026
114 pages
Global Hospital-Acquired Pneumonia Prevention Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... the global Hospital-Acquired Pneumonia Prevention market. Chapter 1, to describe Hospital-Acquired Pneumonia Prevention Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Hospital-Acquired Pneumonia Prevention ...
January 2026
95 pages
The 2027-2032 World Outlook for Anti-Jamming
US$ 1,195.00
This study covers the world outlook for anti-jamming across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Communicable Diseases
US$ 1,195.00
This study covers the world outlook for communicable diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
288 pages
The 2027-2032 World Outlook for Community Acquired Pneumonia
US$ 1,195.00
This study covers the world outlook for community acquired pneumonia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
290 pages
The 2027-2032 World Outlook for Cryptococcosis
US$ 1,195.00
This study covers the world outlook for cryptococcosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages